We also explored gene expression and alteration, signaling pathways, immune infiltration, protein phosphorylation and overall patient survival to characterize the nature of AQP4 in the biology and clinical prognosis in patients with CNS cancers. This evidence concerns the gene AQP4 and central nervous system cancer.